Facilitating best practice - cardiovascular risk management for patients with diabetes

被引：0

作者：

Bootle, S ^{[1
]}

机构：

[1] Healthcare Continuum, High Peak SK23 7BW, England

来源：

DIABETES OBESITY & METABOLISM | 2003年 / 5卷

关键词：

D O I：

10.1046/j.1462-8902.2003.0308.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S29 / S34

页数：6

共 50 条

[41] Cardiovascular Risk Management in Type 1 Diabetes
I. H. Teoh
P. Elisaus
J. D. Schofield
[J]. Current Diabetes Reports, 2021, 21
[42] Cardiovascular absolute risk assessment and management Engagement and outcomes in general practice patients
Wan, Qing
Zwar, Nicholas
Vagholkar, Saniyot
Campbell, Terry
Harris, Mark
[J]. AUSTRALIAN FAMILY PHYSICIAN, 2010, 39 (12) : 954 - 958
[43] Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
Lorber, Daniel
[J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 169 - 183
[44] Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Semb, Anne Grete
Rollefstad, Silvia
Ikdahl, Eirik
Wibetoe, Grunde
Sexton, Joseph
Crowson, Cindy
van Riel, Piet
Kitas, George
Graham, Ian
Rantapaa-Dahlqvist, Solbritt
Karpouzas, George Athanasios
Myasoedova, Elena
Gonzalez-Gay, Miguel A.
Sfikakis, Petros P.
Tektonidou, Maria G.
Lazarini, Argyro
Vassilopoulos, Dimitrios
Kuriya, Bindee
Hitchon, Carol
Stoenoiu, Maria Simona
Durez, Patrick
Pascual-Ramos, Virginia
Galarza-Delgado, Dionicio Angel
Faggiano, Pompilio
Misra, Durga Prasanna
Borg, Andrew A.
Mu, Rong
Mirrakhimov, Erkin M.
Gheta, Diane
Douglas, Karen
Agarwal, Vikas
Myasoedova, Svetlana
Krougly, Lev
Popkova, Tatiana Valentinovna
Tuchynova, Alena
Tomcik, Michal
Vrablik, Michal
Lastuvka, Jiri
Horak, Pavel
Medkova, Helena Kaspar
Kerola, Anne M.
[J]. RMD OPEN, 2021, 7 (02):
[45] Cardiovascular risk management in type-2 diabetes: Is the patients' cardiovascular risk adequately considered in type-2 specialist diabetes care?
Brenner, Sophie
Daikeler, Richard
Oberaigner, Willi
Stummer, Harald
[J]. ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2021, 167 : 6 - 14
[46] Advances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus
Hu Ying
[J]. 慢性疾病与转化医学(英文), 2019, 5 (01) : 25 - 36
[47] Diabetic foot ulcer risk assessment and prevention in patients with diabetes: a best practice implementation project
Yang, Lixiao
Wu, Yanni
Zhou, Chunlan
Xie, Cuihua
Jiang, Ya
Wang, Run
Ye, Xiaoling
[J]. JBI EVIDENCE IMPLEMENTATION, 2022, 20 (04): : 269 - 279
[48] Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes
Schernthaner, Guntram
Jarvis, Sarah
Lotan, Chaim
Prazny, Martin
Wanner, Christoph
Wascher, Thomas C.
[J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 69 - 79
[49] Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice
Marchal, Suzanne
van 't Hof, Arnoud W. J.
Bilo, Henk J. G.
Deijns, Sander J.
Heeg, Jan Evert
Schoenmakers, Marieke
Schouwink, Michiel
Schwantje, Olof
Bots, Michiel L.
Hoes, Arno W.
Hollander, Monika
[J]. BJGP OPEN, 2021, 5 (02) : 1 - 13
[50] Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: The "EPIDAURO registry"
Faden, G.
Viapiana, O.
Fischetti, F.
Faganello, G.
Gatti, D.
Tarantini, L.
Di Lenarda, A.
Adami, S.
Tincani, A.
Filippini, M.
Rossini, M.
Faggiano, P.
Cioffi, G.
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (02) : 534 - 536

← 1 2 3 4 5 →